Home News Regeneron’s COVID-19 treatment gets emergency approval from FDA

Regeneron’s COVID-19 treatment gets emergency approval from FDA



The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to President Trump.

The treatment is aimed at those with mild cases of COVID-19, and not for those hospitalized as a result of the virus, the FDA said.

The treatment works by mimicking the body’s own immune system to prevent the infected from become severely ill.

Regeneron’s drug is a combination of two monoclonal antibodies. A similar drug developed by Eli Lilly & Co. gained FDA emergency clearance earlier this month.

However the Regeneron treatment may not be immediately widely available: the company has said it will have just 80,000 doses by the end of November.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

China has reached a major milestone in ending absolute poverty. But the Communist Party isn't celebrating yet

The rush to the cities has left rural communities with shrinking populations and fewer job opportunities. In the face of this decline, Xi's...

Keith Pelley lauds 'new era for global golf' after European and PGA Tours announce partnership

European Tour chief Keith Pelley lauds 'new era for global golf'...

Robin Goodfellow's Racing Tips: Best bets for Saturday, November 28

Robin Goodfellow's Racing Tips: Best bets for Saturday, November 28By Sam...

SIR CLIVE WOODWARD: Let's see if England can get to another level against Wales

SIR CLIVE WOODWARD: I'm expecting a convincing England win against Wales...

Recent Comments